Literature DB >> 11992577

Increased frequency of IFN-gamma-producing peripheral CD8+ T cells with memory-phenotype in patients with chronic hepatitis C.

Masayuki Murata1, Shigeki Nabeshima, Naoyasu Maeda, Hisashi Nakashima, Seizaburo Kashiwagi, Jun Hayashi.   

Abstract

To identify the capacity for cytokine production and the phenotypic characteristics of peripheral CD8(+) T cells in patients with chronic hepatitis C, 31 patients with chronic hepatitis C and 22 healthy controls were studied at the single cell level by three-color flow cytometry. Whole blood was stained with surface CD8, intracellular interferon-gamma (IFN-gamma), and interleukin-4 (IL-4), surface CD8, CD28, and intracellular IFN-gamma after stimulation with PMA plus ionomycin, and then surface CD8, CD45RA, and CD28. IFN-gamma-producing peripheral CD8(+) T cells were found frequently in patients than in controls (P < 0.05), whereas IL-4-producing peripheral CD8(+) T cells were not. Although the frequency of peripheral CD28(+)CD8(+) and CD28(-)CD8(+) T cells in patients was not different from that of controls, CD28(+)CD8(+) T cells exceeded CD28(-)CD8(+) T cells in the capacity for IFN-gamma-production after mitogenic stimulation (P < 0.01). In a more detailed analysis of the CD28(+)CD8(+) T cells, CD45RA(-)CD28(+)CD8(+) T cells, defined phenotypically as memory cells, were found frequently in patients than in controls (P < 0.05). There were no significant correlations between the frequency of IFN-gamma-producing peripheral CD8(+) T cells and hepatitis C virus RNA level or serum alanine aminotransferase level in patients. These data suggest that functionally T cytotoxic type 1 and memory CD8(+) T cells are predominant in the peripheral blood of chronic hepatitis C patients and that such activated CD8(+) T cells are associated with liver damage. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992577     DOI: 10.1002/jmv.2205

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

Review 1.  Cytokines and HCV-related autoimmune disorders.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Ilaria Ruffilli; Poupak Fallahi
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 2.  Endocrine manifestations of hepatitis C virus infection.

Authors:  Alessandro Antonelli; Clodoveo Ferri; Silvia Martina Ferrari; Michele Colaci; Domenico Sansonno; Poupak Fallahi
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

Review 3.  Immunological alterations in hepatitis C virus infection.

Authors:  Vincenza Calvaruso; Antonio Craxì
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

Review 4.  Cytokines and HCV-related disorders.

Authors:  Poupak Fallahi; Clodoveo Ferri; Silvia Martina Ferrari; Alda Corrado; Domenico Sansonno; Alessandro Antonelli
Journal:  Clin Dev Immunol       Date:  2012-05-07

Review 5.  Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection.

Authors:  Poupak Fallahi; Silvia Martina Ferrari; Ugo Politti; Dilia Giuggioli; Clodoveo Ferri; Alessandro Antonelli
Journal:  Int J Endocrinol       Date:  2014-10-13       Impact factor: 3.257

6.  Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapy.

Authors:  Zohreh Jadali
Journal:  Indian J Endocrinol Metab       Date:  2013-01

7.  CD49b, a major marker of regulatory T-cells type 1, predicts the response to antiviral therapy of recurrent hepatitis C after liver transplantation.

Authors:  Stenard Fabien; Morales Olivier; Ghazal Khaldoun; Viallon Vivian; Aoudjehane Lynda; Ouaguia Laurissa; Goormachtigh Gautier; Calmus Yvon; Delhem Nadira; Conti Filomena
Journal:  Biomed Res Int       Date:  2014-01-19       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.